USS Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-35,917
Closed -$849K – 596
2022
Q4
$849K Hold
35,917
– – 0.01% 564
2022
Q3
$912K Buy
35,917
+679
+2% +$23.8K 0.01% 557
2022
Q2
$1.17M Sell
35,238
-1,414
-4% -$60.1K 0.01% 591
2022
Q1
$2.64M Buy
36,652
+6,781
+23% +$489K 0.02% 542
2021
Q4
$2.74M Hold
29,871
– – 0.02% 572
2021
Q3
$3.79M Buy
29,871
+4,769
+19% +$694K 0.03% 503
2021
Q2
$4.17M Hold
25,102
– – 0.03% 292
2021
Q1
$4.56M Buy
25,102
+325
+1% +$75.4K 0.04% 259
2020
Q4
$4.95M Buy
+24,777
New +$5.04M 0.05% 225

Other funds holding TDOC

USS Investment Management's TDOC Position: Q1 2023 in Review

USS Investment Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 35,917 shares — an estimated $849K sold.

USS Investment Management first reported a position in TDOC in Q4 2020 and held it in 9 quarters. The position peaked at $4.95M in Q4 2020. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • USS Investment Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • USS Investment Management sold 35,917 Teladoc Health shares in Q1 2023, an estimated $849K.
  • USS Investment Management first reported a position in Teladoc Health in Q4 2020 and held it in 9 quarters.
  • USS Investment Management's Teladoc Health position peaked at $4.95M in Q4 2020.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on USS Investment Management's 13F filing for Q1 2023, filed 15 May 2023.